MARSHALL WACE, LLP - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 49 filers reported holding PLX PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PLX PHARMA INC
ValueSharesWeighting
Q2 2022$98,000
+10.1%
40,154
+262.3%
0.00%
Q4 2021$89,000
-91.8%
11,084
-80.4%
0.00%
-100.0%
Q3 2021$1,091,000
-80.9%
56,528
-86.4%
0.01%
-80.8%
Q2 2021$5,716,000
+138.4%
414,186
+56.0%
0.03%
+136.4%
Q1 2021$2,398,000265,4620.01%
Other shareholders
PLX PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 36,407$292,0001.70%
FRIESS ASSOCIATES LLC 278,071$2,227,0000.87%
MSD Partners, L.P. 5,625,000$45,057,0000.49%
Park West Asset Management LLC 1,473,218$11,800,0000.23%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$502,0000.23%
O'Brien Greene & Co. Inc 60,340$483,0000.16%
Eidelman Virant Capital 27,000$219,0000.08%
Heritage Way Advisors, LLC 25,000$200,0000.08%
GW&K Investment Management, LLC 432,871$3,467,0000.03%
Alpine Global Management, LLC 16,380$131,0000.02%
View complete list of PLX PHARMA INC shareholders